Zoetis launches Suvaxyn® PRRS MLV in the European Union
Zoetis announce the launch of Suvaxyn® PRRS MLV in most European Union countries, an innovative vaccine containing a modified live European Porcine Reproductive and Respiratory Syndrome (PRRS) virus strain, grown in a unique cell line for whole herd protection against PRRS.